There is a deadly foe of our ladies & its name is epithelial ovarian cancer (EOC). It certainly will
will make ladies pass away due to gynecologic malignancy. The effects of consolidation therapy
varied in numerous research studies.
One trial in particular took a closer look at the results of 12 cycles single agent paclitaxel within
our ladies that were given the surgical debulking, and 6 courses of the chemptherapy that is bas-
ed in platinum.
They were assigned to 12 cycles of single agent paclitaxel which was administered every 28 da-
ys. The conductors decided to follow-up for progression free survival, toxicity, & life quality. The
researchers needed 43 ovarian cancer patients for the study.
Twenty-three of them were situated in the case group and twenty of those ladies were placed in
a control group. The median progression free survival was actually 7 months longer in the case
group than the control group (14 months against 7 months, p=0.015).
The overall survival was kind of close (31.1 months against 30.5 months, p=0.17). The situation r-
egarding the therapy-related neuropathy and life quality fared greater in the control group than the
case one. The conductors tried hard to assist our ill ladies.
No comments:
Post a Comment